Sophia Genetics Receives CE-IVD Mark For Genetic Testing Of Familial Mediterranean Fever And Hypercholeteromia
LAUSANNE, Switzerland, September 24, 2014 /PRNewswire/ --
Sophia Genetics, the European leader in NGS data analysis, has received the CE-IVD mark for genetic testing of Familial Mediterranean Fever and Hypercholeteromia.
The quality assurance guarantee for these three tests follows receipt of CE-IVD certification for Sophia's NGS bioinformatics pipeline for use in routine genetic testing, further strengthening standards of testing and clinical diagnosis of congenital diseases.
Sophia Genetics' CE-IVD and ISO 13485-accredited Data Driven Medicine platform reduces the cost and time associated with compliance for clinical laboratories with both the new CE-IVD Directive as well as the requirements for ISO 15189 accreditation. As part of its commitment to quality, Sophia Genetics will seek to obtain the CE-IVD mark for each of the genetic tests it supports.
Jurgi Camblong, CEO of Sophia Genetics, said:
"Data Driven Medicine is transforming our ability to address congenital diseases. But there is a real need for solutions which can analyse the data produced by NGS sequencing to a clinical standard. At Sophia Genetics, we are dedicated to solving some of the toughest problems in data analysis and making clinical diagnosis much simpler, faster and easier for our lab customers."
About CE-IVD
The CE-mark (CE-IVD) indicates that an IVD device complies with the European In Vitro Diagnostics Directive (98/79/EC), and that the device may be legally commercialized and distributed in the EU.
About Sophia Genetics
Sophia Genetics, a European leader in Data Driven Medicine, brings together expertise in clinical genetics, bioinformatics, machine learning, and genomic privacy. Based in Switzerland, we are known for our high medical standards and Swiss precision when it comes to accuracy and quality management. Sophia Genetics offers health professionals who perform clinical genetic testing bioinformatics analysis, quality assurance, and secure banking of patient DNA sequence data generated by NGS. Sophia Genetics helps clinical laboratories to reduce the cost, overcome complexity and fulfill quality constraints related to the use of NGS in the clinic. http://www.sophiagenetics.com
Help employers find you! Check out all the jobs and post your resume.